In his state of the union address last night, President Trump said reducing prescription drug prices is “one of my greatest priorities.” Among other health care-related comments, Trump said his administration “is committed to fighting the drug epidemic and helping get treatment for those in need.” He also said it is “time to rebuild our crumbling infrastructure,” and called on Congress to produce a bill that generates at least $1.5 trillion for new infrastructure investment. Commenting on the speech, AHA President and CEO Rick Pollack said, “Along with the Administration’s commitment to reversing the tide of drug addiction and addressing the rising costs of prescription drugs, we support the need to address America’s infrastructure. Hospitals and health care should be part of any effort to fix and improve our nation’s infrastructure. Just as America’s infrastructure must be rebuilt, our health care infrastructure must also be revitalized. More specifically, infrastructure investments are needed to help hospitals meet the needs of their communities, strengthen the capacity for emergency preparedness and response, expand the digital infrastructure for health care, and ensure adequate financing mechanisms for hospitals and health systems. We appreciate the Administration’s support for revitalizing advanced refinancing for tax-exempt bonds.”

Related News Articles

Headline
The AHA Sept. 8 urged the Federal Trade Commission and Antitrust Division of the Department of Justice to investigate several drug companies’ concerted efforts…
Headline
The Department of Health and Human Services today announced prescription drug reforms that will become effective Oct. 1 originating from the Health Data,…
Headline
The AHA’s Society for Health Care Strategy & Market Development Aug. 21 announced Donna Teach, chief marketing and communications officer for Nationwide…
Perspective
Public
The job description for the ideal health care leader in coming years might read something like this:Wanted: Bold, compassionate innovator who unites clinical…
Headline
The Trump administration today announced steps drug manufacturers must take to lower prescription drug prices in the U.S. to "most favored nation" pricing, the…
Headline
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug…